Overview
Neulasta is a prescription drug approved by the Food and Drug Administration (FDA) to lower the risk of developing infections after receiving chemotherapy or some types of radiation. Neulasta is also known by…

Overview
Opdivo is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat cancers including classic Hodgkin lymphoma. Opdivo is indicated in cases where lymphoma has relapsed or progressed…

Overview

Polivy is approved by the U.S. Food and Drug Administration (FDA) for the treatment of certain types of large B-cell lymphoma. It is indicated in combination with a rituximab product, cyclophosphamide…

Overview
Poteligeo is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with relapsed or refractory mycosis fungoides (MF) and adults with relapsed or refractory Sézary syndrome…

Overview
Revlimid is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat mantle cell lymphoma and multiple myeloma. Revlimid is often combined with other drugs such as a…

Overview
Riabni (rituximab-arrx) is a U.S. Food and Drug Administration (FDA)-approved treatment for adults with non-Hodgkin’s lymphoma (NHL), a type of cancer that affects the lymphatic system (part of the immune system…

Overview
Rituxan is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat non-Hodgkin lymphoma. Rituxan may be prescribed alone or in combination with other antilymphoma drugs. Rituxan may…

Overview
Rituxan Hycela is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat follicular lymphoma, diffuse large B-cell lymphoma (DLBCL), and chronic lymphocytic leukemia (CLL). Rituxan…

Overview
Ruxience (rituximab-pvvr) is a U.S. Food and Drug Administration (FDA)-approved treatment for adults with non-Hodgkin’s lymphoma (NHL), a type of cancer that starts in the lymphatic system (part of the immune…

Overview
Tecartus is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat relapsed or refractory mantle cell lymphoma (MCL) in adults. Tecartus is only available through a…

Overview
Treanda is a prescription medication approved by the U.S. Food and Drug Administration (FDA) for treating chronic lymphocytic leukemia and indolent B-cell non-Hodgkin lymphoma. Treanda is sometimes prescribed as…

Overview
Truxima (rituximab-abbs) is a U.S. Food and Drug Administration (FDA)-approved treatment for adults with non-Hodgkin’s lymphoma (NHL), a type of cancer that starts in the lymphatic system (part of the immune…

Overview
Velcade, also known by its drug name bortezomib, is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat mantle cell lymphoma and multiple myeloma. Velcade is often combined…

Overview
Venclexta is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) and adults over 75 years old…

Overview

Vinblastine is a prescription medication used to treat several types of cancer including Hodgkin lymphoma (stages 3 and 4), lymphocytic lymphoma, histiocytic lymphoma, and mycosis fungoides. Vinblastine is often…

Overview
Xalkori is approved by the U.S. Food and Drug Administration (FDA) for treating certain cancers that are positive for anaplastic lymphoma kinase (ALK) or ROS1. Among its specific indications, it’s approved for…

Overview
Yescarta is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with large B-cell lymphoma. Yescarta is indicated when lymphoma is relapsed or refractory and at least two…

Overview
Zevalin is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat non-Hodgkin lymphoma (NHL). Specifically, Zevalin is indicated for use in low-grade or follicular B-cell lymphoma…

Overview
Zolinza is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat skin symptoms in people with cutaneous T-cell lymphoma (CTCL). Zolinza is indicated for use in patients when…

Overview
Zydelig is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat relapsed cases of follicular B-cell non-Hodgkin lymphoma, small lymphocytic lymphoma (SLL), and chronic lymphocytic…

Overview
Zynlonta is approved by the U.S. Food and Drug Administration (FDA) for the treatment of adults with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. This includes…